Skip to main content

A Patient with a Large Hürthle Cell Carcinoma of the Thyroid and Nodal Metastases

  • Chapter
Thyroid Cancer
  • 1919 Accesses

Abstract

A patient presented with a large thyroid nodule that was eventually diagnosed as a Hürthle cell variant of follicular thyroid carcinoma. The case is unusual in its presentation with locoregional lymph node metastases, generally thought to be characteristic of papillary thyroid carcinoma but not follicular thyroid carcinoma. The patient illustrates the typical presentation of Hürthle cell carcinoma, in that he was of advanced age and the nodule lacked calcification on ultrasonography and was relatively large. The case illustrates the difficulty in differential diagnosis based upon cytology alone and the need for aggressive initial management with surgery and radioiodine when there is pathologic evidence of a highly invasive nature of the tumor. Unfortunately, many of these tumors are either radioiodine uptake negative or radioresistant, and other modalities of therapy are often required.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rossi ED, Martini M, Straccia P, Raffaelli M, Pennacchia I, Marrucci E, Lombardi CP, Pontecorvi A, Fadda G. The cytologic category of oncocytic (Hürthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience. Eur J Endocrinol. 2013;169(5):649–55.

    Article  CAS  PubMed  Google Scholar 

  2. Auger M. Hürthle cells in fine-needle aspirates of the thyroid: a review of their diagnostic criteria and significance. Cancer Cytopathol. 2014;122(4):241–9.

    Article  PubMed  Google Scholar 

  3. Lee KH, Shin JH, Ko ES, Hahn SY, Kim JS, Kim JH, Oh YL. Predictive factors of malignancy in patients with cytologically suspicious for Hürthle cell neoplasm of thyroid nodules. Int J Surg. 2013;11(9):898–902.

    Article  PubMed  Google Scholar 

  4. Sippel RS, Elaraj DM, Khanafshar E, Zarnegar R, Kebebew E, Duh QY, Clark OH. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid. World J Surg. 2008;32(5):702–7.

    Article  PubMed  Google Scholar 

  5. Strazisar B, Petric R, Sesek M, Zgajnar J, Hocevar M, Besic N. Predictive factors of carcinoma in 279 patients with Hürthle cell neoplasm of the thyroid gland. J Surg Oncol. 2010;101(7):582–6.

    Article  PubMed  Google Scholar 

  6. Suh I, Vriens MR, Guerrero MA, Griffin A, Shen WT, Duh QY, Clark OH, Kebebew E. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hürthle-cell neoplasms of the thyroid. Am J Surg. 2010;200:41–6.

    Article  CAS  PubMed  Google Scholar 

  7. Yip L, Wharry LI, Armstrong MJ, Silbermann A, McCoy KL, Stang MT, et al. A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy. Ann Surg. 2014;260:163–7.

    Article  PubMed  Google Scholar 

  8. McCoy KL, Carty SE, Armstrong MJ, Seethala RR, Ohori NP, Kabaker AS, et al. Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer. J Am Coll Surg. 2012;215:546–54.

    Article  PubMed  Google Scholar 

  9. Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7:569–80.

    Article  CAS  PubMed  Google Scholar 

  10. Gupta N, Dasyam AK, Carty SE, Nikiforova MN, Ohori NP, Armstrong M, et al. RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular pattern cancers. J Clin Endocrinol Metab. 2013;98:E914–22.

    Article  PubMed  Google Scholar 

  11. Maizlin ZV, Wiseman SM, Vora P, Kirby JM, Mason AC, Filipenko D, Brown JA. Hürthle cell neoplasms of the thyroid: sonographic appearance and histologic characteristics. J Ultrasound Med. 2008;27(5):751–7.

    PubMed  Google Scholar 

  12. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov Y, et al. American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015; 24.

    Google Scholar 

  13. Riemann B, Uhrhan K, Dietlein M, Schmidt D, Kuwert T, et al. Diagnostic value and therapeutic impact of (18)F-FDG-PEET-CT in differentiated thyroid cancer. Results of a German multicentre study. Nuklearmedizin. 2013;53:1–6.

    Article  Google Scholar 

  14. Pauleau G, Palazzo FF, Essamet W, Sebag F, Taieb D. Hürthle cell neoplasms: a new differential diagnosis of 18F-FDOPA-avid thyroid nodules? J Clin Endocrinol Metab. 2013;98:865–6.

    Article  CAS  PubMed  Google Scholar 

  15. Lee J, Hasteh F. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto’s thyroiditis: a case report and review of the literature. Diagn Cytopathol. 2009;37(8):600–6.

    Article  PubMed  Google Scholar 

  16. Mai KT, Khanna P, Yazdi HM, Perkins DG, Veinot JP, Thomas J, Lamba M, Nair BD. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular. Hürthle cell and papillary thyroid carcinoma. Pathology. 2002;34:239–44.

    Article  PubMed  Google Scholar 

  17. Mills SC, Haq M, Smellie WJ, Harmer C. Hürthle cell carcinoma of the thyroid: retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol. 2009;35(3):230–4.

    Article  CAS  PubMed  Google Scholar 

  18. Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. Thyroid. 2012;22(7):690–4.

    Article  PubMed  Google Scholar 

  19. Kuo EJ, Roman SA, Sosa JA. Patients with follicular and Hürthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients. Surgery. 2013;154:1246–53.

    Article  PubMed  Google Scholar 

  20. Haigh PI, Urbach DR. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery. 2005;138:1152–7.

    Article  PubMed  Google Scholar 

  21. Ganly I, Ricarte FJ, Eng S, Ghossein R, Morris LG, Liang Y, Socci N, Kannan K, Mo Q, Fagin JA, Chan TA. Genomic dissection of Hürthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013;98:E962–72.

    Article  PubMed  Google Scholar 

  22. Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B. Prognostic factors of recurrence in encapsulated Hürthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 2006;106:1669–76.

    Article  PubMed  Google Scholar 

  23. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, et al. Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma? Ann Surg Oncol. 2013;20(9):2944–50.

    Article  PubMed  Google Scholar 

  24. Takashima S, Sone S, Takayama F, Wang Q, Kobayashi T, Horii A, Yoshida JI. Papillary thyroid carcinoma: MR diagnosis of lymph node metastasis. AJNR Am J Neuroradiol. 1998;19:509–13.

    CAS  PubMed  Google Scholar 

  25. Gross ND, Weissman JL, Talbot JM, Andersen PE, Wax MK, Cohen JI. MRI detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope. 2001;111:1905–9.

    Article  CAS  PubMed  Google Scholar 

  26. Foote RL, Brown PD, Garces YI, McIver B, Kasperbauer JL. Is there a role for radiation therapy in the management of Hürthle cell carcinoma? Int J Radiat Oncol Biol Phys. 2003;56:1067–72.

    Article  PubMed  Google Scholar 

  27. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. Am J Roentgenol. 2002;178:699–704.

    Article  CAS  Google Scholar 

  28. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130:971–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Wartofsky, L. (2016). A Patient with a Large Hürthle Cell Carcinoma of the Thyroid and Nodal Metastases. In: Cooper, D., Durante, C. (eds) Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-22401-5_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22401-5_24

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22400-8

  • Online ISBN: 978-3-319-22401-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics